Patients & Care Partners
Clinical Trials
To every patient and care partner who has participated in a clinical trial, thank you. Your willingness to share your time, your experiences, and your trust is an extraordinary act of generosity.
We know that participating in research is not always easy, and it often comes at a time when you’re already navigating so much. Your partnership helps move science forward in ways that wouldn’t be possible otherwise, creating hope and new possibilities for others facing similar journeys. We are deeply grateful for your courage, your commitment, and your belief in making a difference for the entire pulmonary fibrosis community.
Filter By:
Active
AP01
Phase 2b MIST Study Recruiting
A Phase 2b Study Evaluating the Safety and Efficacy of AP01 (inhaled pirfenidone) in Participants With Progressive Pulmonary Fibrosis (PPF)
Learn more about MIST PPF Study
visit study #NCT06329401 clinical trials.GOV >
AP02
Phase 1b Study Recruiting
A Phase 1 Study of AP02 (Nintedanib Solution for Inhalation) Delivered via the PARI eFlow® Nebulizer System to Evaluate the Safety, Tolerability, and Pharmacokinetics of AP02 in Healthy Volunteers
visit study #NCT07194382 clinical trials.GOV >
Completed
AP01
Phase 1b ATLAS Study Completed
A Randomized Open-Label, Phase 1b Study of the Safety of Pirfenidone Solution for Inhalation (AP01) in Patients with Idiopathic Pulmonary Fibrosis
AP02
Phase 1a Study Completed
A Phase 1 Study of AP02 (Nintedanib Solution for Inhalation) Delivered via the PARI eFlow® Nebulizer System in Healthy Volunteers and Patients with Idiopathic Pulmonary Fibrosis or Progressive Fibrosing Interstitial Lung Disease
